Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus (LES-HYDROXY)

  • STATUS
    Recruiting
  • participants needed
    50
  • sponsor
    University Hospital, Toulouse
Send
Updated on 8 December 2023
See if I qualify

Summary

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.

The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

Details
Condition Lupus Erythematosus
Age 18years - 75years
Treatment The Morisky Medication Adherence Scale
Clinical Study IdentifierNCT06161363
SponsorUniversity Hospital, Toulouse
Last Modified on8 December 2023

Eligibility

 Yes No Not Sure

Inclusion Criteria

Age >18 years
Patient with systemic lupus erythematosus
Treatment with PLAQUENIL for > 6 months with dosage of hydroxychloroquinemia planned during the consultation
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.